SGLT-2-Hemmer-assoziierte Schwere Diabetische Ketoazidose

Forum Médical Suisse ‒ Swiss Medical Forum
doi 10.4414/fms.2016.02617
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Diabetische Ketoazidose Unter Empagliflozin

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2019English

SGLT2-Hemmer Als Ursache Für Die Entstehung Einer Ketoazidose

Diabetologie und Stoffwechsel
EndocrinologyMetabolismDiabetes
2019English

SGLT-2 Inhibitors – Are They to Stay?

Diabesity
2017English

Das Diabetische Fußsyndrom

Der Internist
Internal Medicine
2011English

Diabetische Retinopathie

Huisarts en Wetenschap
Family Practice
2003English

Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis

European Scientific Journal ESJ
2019English

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Metabolic Syndrome and Related Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Relationship Between Euglycemic Diabetic Ketoacidosis and SGLT-2 Inhibitors

Global Journal of Endocrinological Metabolism
2018English

IgG4-assoziierte Erkrankung

Zeitschrift fur Rheumatologie
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy